| ID | 119126 |
| Author |
Okada, Masaki
Sakamoto Hospital
Iwatsuki, Noboru
Sakamoto Hospital
Sakamoto, Kazuki
Sakamoto Hospital
Ogawa, Tomoya
Sakamoto Hospital
|
| Keywords | Imeglimin (Twymeeg)
Type 2 Diabetes
Zinc Acetate Hydrate
Novelzin
Trials of IMeglimin for Efficacy and Safety
Neuropsychiatric Symptoms in Dementia
Alzheimer's-Plus with Low Zinc
|
| Content Type |
Journal Article
|
| Description | Background: Recent diabetic focus includes imeglimin (Twymeeg).
Case Presentation: The case was an 83-year-old female with 19 years of type 2 diabetes (T2D) associated with recent treatment for dementia. Result: HbA1c decreased from 10.0% to 6.6% for 4 months by Twymeeg 2000 mg/day. For neuropsychiatric symptoms in dementia, memantine and tiapride were provided and controlled. Furthermore, zinc acetate hydrate (Novelzin) was continued for T2D and dementia. Discussion and Conclusion: Twymeeg administration was effective as the results of Trials of IMeglimin for Efficacy and Safety (TIMES) 2 and 3. Perspectives on the efficacy of zinc were discussed including Alzheimer's-Plus with low zinc (APLZ). |
| Journal Title |
Asploro Journal of Biomedical and Clinical Case Reports
|
| ISSN | 25820370
|
| Publisher | Asploro
|
| Volume | 6
|
| Issue | 1
|
| Start Page | 17
|
| End Page | 22
|
| Published Date | 2023-02-04
|
| Rights | This is an open-access article distributed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
|
| DOI (Published Version) | |
| URL ( Publisher's Version ) | |
| FullText File | |
| language |
eng
|
| TextVersion |
Publisher
|
| departments |
Medical Sciences
|
